E Faulkner, L Annemans, L Garrison, M Helfand, AP Holtorf, J Hornberger, D Hughes, et al. “Challenges in the Development and Reimbursement of Personalized Medicine—Payer and Manufacturer Perspectives and Implications for Health Economics and Outcomes Research: A Report of the ISPOR Personalized Medicine Special Interest Group.” Value Health 15, 1162–1171 (2012).
C McAdam-Marx, DT Schaaf, AP Holtorf, Benjamin Eng, GM. Oderda. Systematic Analysis of Outcomes Evaluations Applied to Drug Management Programs. Am J Manag Care. 2008;14(11 Spec No.):SP36-SP45.
A.-P. Holtorf (1999) A common direction – Collaborations and contributions towards quality in healthcare, Invited lecture at the XII Malente Symposium, Dräger Foundation, Lübeck: Health Care Systems at Crossroads: Balancing Individual Needs with Financial Limitations.
Harald Rinde. “Chapter 8: Disease Management in Pharmaceutical Companies” Editor: J. Couch Epilogue: James, Bill First, Foreword: Philip Caper [The Health Care Professional’s Guide to Disease Management: Patient-Centered Care for the 21st Century. Aspen Publications, USA] First edition: 1997; Second edition: 1998